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Humans live in a close association with a complex microbial ecosystem that is collectively termed 
microbiota. Microbiota is concentrated in the last part of the gastrointestinal tract, where it ferments 
undigested food residues and produces various metabolites that have a systemic influence on human 
physiology. The composition of microbiota is influenced by genetic and environmental factors that 
shape a unique ecosystem in each human. Despite considerable compositional variations, the 
functional output of the ecosystem is highly similar in all healthy individuals. Although it is still not 
possible to define normal microbiota, comparisons between patients suffering from a number of 
chronic diseases with unknown etiology and controls have shown that patients have specific, 
dysbiotic microbiota composition. While it still remains to be determined if the microbiota dysbiosis 
is an etiological factor or a consequence of a disease, these findings have initiated intensive 
microbiota research. Numerous proven functions of microbiota include contribution to the digestion, 
synthesis of essential metabolites (vitamins and amino acids) and the intensive crosstalk with the 
immune, the endocrine and the nervous system. Even though this field of research is still in an early 
stage, it is clear that microbial metabolites can have various effects on humans including direct 
beneficial effect, toxicity, but also more subtle interactions since microbial products can act as 
immune regulating or neuro-signaling molecules. The complex network of bidirectional interactions 
between microbiota and humans is unexplored but highly potent for development of novel strategies 
to preserve and improve health.  
 






Humans live in a close relationship with microorganisms that are collectively 
termed microbiota. Two other terms are also widely used to refer to the same 
ecosystem. Microflora is a synonym that is currently abandoned since biota indicates 
presence of living beings, while flora is used as collective term for plants. 
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Microbiome was originally introduced as a term to refer to collective microbial 
genomes, although today it is used as a term to collectively address microorganisms, 
their genomes and the surrounding environmental conditions (Marchesi & Ravel, 
2015). The majority of human-associated microorganisms are inhabiting the 
digestive tract, in particular the colon, although nasal passage, oral cavity, skin and 
urogenital tract are also densely populated (The Human Microbiome Project, 2012). 
Traditionally, human associated microorganisms were considered as commensals, 
indicating the absence of any harmful but also beneficial activity towards the host. 
However, current research proved a whole range of beneficial effects of human 
microbiota suggesting that associated microoganisms are symbiotic species essential 
for our wellbeing. The recognition of the microbiota's importance is probably the 
best illustrated through a suggestion that it should be considered as a "forgotten 
organ" (O'Hara & Shanahan, 2006). 
The symbiotic relationship between higher animals and associated 
microorganisms has been recognized for a long time for herbivores, in particular 
ruminants, as extraction of energy from ingested food in these animals is highly 
dependent on enzymatic activity of their intestinal microbes (Jami, Israel, Kotser, & 
Mizrahi, 2013). Humans similar to other omnivores do not depend in such a large 
extent on the energy extracted by fermentation. It is clear that human intestinal 
microbiota also contributes to energy extraction from indigested food (Cummings & 
Macfarlane, 1997), the colon should be considered as a sophisticated bioreactor 
(Swidsinski et al., 2016), which activity has much more complex impact on human 
health. Numerous functions of gut microbiota include synthesis of essential amino 
acids and vitamins, contribution to steroid molecules circulation (including bile acids 
and sex hormones), education of the immune system and production of various 
bioactive compounds with systemic impact on health (Rajilić-Stojanović, 2013). 
The microbiota is very complex as it is composed of representatives of all three 
domains of life – Bacteria, Archaea and Eukarya accompanied by viruses (Rajilić-
Stojanović & de Vos, 2014). However, bacteria are by far the most predominant and 
in most studies the only studied component of the ecosystem. There are thousands of 
possible microbial inhabitants, although each of human is populated by 
approximately 500 species that represent a unique and stable ecosystem. There is 
quite some controversy regarding the stability of the microbiota. On one hand it has 
been shown that various life style changes including dietary shift of quitting smoking 
can cause changes in the gut microbiota (Biedermann et al., 2014; Wu et al., 2011). 
On the other hand, one of the first applications of molecular profiling techniques have 
indicated stable and individual-specific microbiota signature (Zoetendal, 
Akkermans, & de Vos, 1998). The reason for, on the first sight, contradictory reports 
is primarily methodological. The majority of microbiota studies employ sequencing 
and quantitative interpretation of the obtained number of reads per taxonomic group. 
This approach is not sensitive enough to identify microbiota profiles irrespective of 
quantitative contribution of particular taxa in the ecosystem. However, ultra-deep 
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sequencing and DNA microarrays application on samples collected over periods 
longer than a decade have clearly shown that each person harbors microbiota 
composed of particular species that define an individual specific microbiota 
signature, while quantitative contribution of microbiota constituents changes in 
response to environmental triggers (Faith et al., 2013; Rajilić-Stojanović, Heilig, 
Tims, Zoetendal, & de Vos, 2012).  
 
Methods to Study Microbiota 
 
The history of microbiota research is very long, since the first intestinal 
bacterium was isolated from healthy children already in 1886. This first isolate was 
at that time known as Bacillus coli commune, but was renamed to honor its 
discoverer – dr Theodor Escherich to Escherichia coli (Shulman, Friedmann, & 
Sims, 2007). For many years intestinal microbiota was studied using classical 
microbiological methods, but the recovery of its members was poor, since the 
majority of intestinal microbes are strict anaerobes. The development of methods for 
anaerobic growth in 1960s (Hungate, 1969), enabled more adequate research of the 
intestinal microbiota and many relevant intestinal species were described in the 
1970s (Finegold et al., 1977; Holdeman & Moore, 1974). Although it was possible 
to capture as many as 88% of intestinal counts, anaerobic cultivation was not widely 
applied due to numerous technical challenges. Namely, for profiling of a single 
sample it was necessary to apply dozens of different cultivation media, at different 
dilutions since intestinal microbes can be present in very different densities (e.g. in 
feces Bacteroides spp. are present up to 1011cells/g (Eggerth & Gagnon, 1933), 
while Actinomyces spp. are present in density of 102-103 cells/g (Hoyles et al., 
2012). Furthermore, due to the enormous and still unexplored diversity it was 
impossible to assign all obtained isolates to species level identity (Moore & 
Holdeman, 1974).  
The true revolution of this field of research occurred with the introduction of 
molecular methods that allowed analysis not only of community structure but also of 
functions of complex ecosystems (Figure 1). In particular, the application of 
sequence analysis of the phylogenetic marker – small subunit ribosomal RNA 
sequence (SSU rRNA) – enabled analysis of the microbial diversity without the need 
for cultivation but also the development of various profiling and quantification 
methods that have shown the importance of the microbiota (Namsolleck et al., 2004). 
SSU rRNA is also referred as 16S rRNA in prokaryotes and 18S rRNA in eukaryotes, 
due to its different size in different life forms. It is a building part of ribosomes and 
its sequence, which is composed of conserved and nine variable regions, has not 
change much through evolution. The level of similarity of the SSU rRNA sequences 
are indicative of the relatedness between species, and the first application of this 
phylogenetic marker facilitated the discovery of the third domain of life – Archaea 
(Woese, Kandler, & Wheelis, 1990). Applied on intestinal isolates, analysis of the 
SSU rRNA sequence indicated the need for reclassification of many of the 
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misclassified species, which is the best illustrated through an example of the 
Clostridium genus (Collins et al., 1994). It was shown that only a small fraction of 
species classified to this genus are highly related and are members of Clostridium 
genus sensu stricto, while others represent members of different genera in distantly 
related families. This led to the reclassification of many species, including C. difficile 
as Clostridioides difficile (Lawson, Citron, Tyrrell, & Finegold, 2016) but also to the 
introduction of so called Clostridium clusters, of which clusters IV and XIVa are 




Figure 1. Schematic representation of molecular methods available for studying microbiota, 
composition and function. 
 
Analysis of the SSU rRNA encoding gene sequence starting from the total 
genomic DNA isolated from an intestinal sample showed that many (about ~80%) 
of the intestinal inhabitants are still uncultured species (Rajilić-Stojanović, Smidt, & 
de Vos, 2007). This indicates that we still know very little about the identity and 
function of our microbial companions. Nevertheless, even without knowing the true 
identity and function of microbiota, compassion between different populations 
showed specific microbiota signatures for different age groups or geographic origin 
(Yatsunenko et al., 2012). Even more relevant are indications of presence of specific 
microbiota structure in relation to different diseases including obesity, diabetes, 
irritable bowel syndrome, colon cancer and autism (Castellarin et al., 2012; Larsen 
et al., 2010; Ley, Turnbaugh, Klein, & Gordon, 2006; Rajilić-Stojanović et al., 2011; 
Williams, Hornig, Parekh, & Lipkin, 2012). This disturbed ecosystem composition 
is often termed dysbiosis in contrast to eubyosis. Both terms are indicating presence 
of a stable ecological state of the microbiota, of which ecosystem in dysbiosis has 
lost a beneficial interaction with the host (Costello, Stagaman, Dethlefsen, 
Bohannan, & Relman, 2012). It is still not clear if dysbiosis precedes the 
development of the disease and therefore is its etiological factor or it is its 
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consequence. However, the experiments with germ free animals indicate that 
microbiota could be an etiological factor since phenotype of several diseases has 
been transferred from patients to experimental animals upon fecal microbiota 
transplantation (Collins, Kassam, & Bercik, 2013; Ridaura et al., 2013).  
Although it is of undoubted interest to study the community structure, it is even 
more relevant to assess the function of the microbiota, to understand its role in human 
health. Here it is important to note that it has been shown that despite differences in 
composition, microbiota performs similar (the same) functions. This phenomenon 
that phylogenetically distant species can perform the same function is known as a 
functional redundancy (The Human Microbiome Project, 2012). Function of the 
microbiota can be assessed by analysis of the produced metabolites (metabolomics), 
total proteins (proteomics) or all transcribed messenger RNAs (transcriptomics, 
Figure 1). The analysis of proteomics and transcriptomics data are linked with 
numerous technical challenges primarily due to the still unexplored identity of the 
majority of proteins and very short life of prokaryotic mRNAs. Therefore, 
transcriptomics studies often instead of mRNA report results of the rRNA analysis, 
which provide insight into active members of the community (Bashiardes, 
Zilberman-Schapira, & Elinav, 2016). Metagenomics is the technique that allows 
researchers to assess the total genomic material, and provide a view of the genetic 
potential of the entire community. Since there is considerable genomic sequence 
variation between strains of the same species (as exemplified on Lactobacillus 
plantarum species (Molenaar et al., 2005) and since for more than half of the cultured 
intestinal species not even a single genome has been sequenced and annotated 
(Rajilić-Stojanović & de Vos, 2014) it is clear that databases for matagenomics data 
interpretation are still immature. Nevertheless, this method combined with ultra-deep 
sequencing can be powerful in revealing both compositional and functional shifts 
associated with various treatments, as shown when studying the effect of metformin 
on microbiota and metabolic parameters of type 2 diabetes patients (Wu et al., 2017). 
 
Factors Shaping Microbiota 
 
Microbiota of each human represents a unique ecosystem that is composed 
under influence of many factors (Figure 2). For a long time it has been believed that 
babies are sterile in the womb and that are inoculated by surrounding microorganisms 
during the delivery. Novel research shows that microbes are present in the amniotic 
fluid, the placenta, the umbilical cord and in the first stool – meconium (Collado, 
Rautava, Aakko, Isolauri, & Salminen, 2016). However there is an important 
influence of the environment and the microbiota that develops in infants born via 
Cesarean (C-)section is notably different than that in vaginally born infants and more 
skin and hospital related microorganisms are found in these babies (Bäckhed et al., 
2015). Since C-section is linked to various health risks including auto-immune 
diseases such as asthma and allergies (Sevelsted, Stokholm, Bønnelykke, & 
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Bisgaard, 2015), it is believed that these risks are linked to the specific microbiota 
signatures found in these babies and strategies were developed to inoculate newborns 
with mother's vaginal microorganisms (Dominguez-Bello et al., 2016). In addition 
to the mode of delivery another important factor that strongly influences microbiota 
development is infant feeding as it has been shown that breast-fed infants have less 
diverse and Bifidobacterium spp. predominated microbiota (Bäckhed et al., 2015). 
Mother's milk contains probiotic microbes, numerous prebiotic acting 
oligosaccharides and antimicrobial peptides (Cabrera-Rubio et al., 2012; Kunz, 
Rudloff, Baier, Klein, & Strobel, 2000), which indicates that this natural food for 
infants is designed to stimulate development of specific microbial community in the 
infants' intestine. This is probably the most illustrative example that shows the natural 




Figure 2. Schematic representation of factors that influence intestinal microbiota 
composition. 
Another important factor that introduces prominent changes in the microbiota 
is the introduction of solid foods. Introduction of solid foods causes microbiota 
diversification (Bäckhed et al., 2015), and it has been shown that too early 
diversification and adult like microbiota in young children might contribute to 
development of the atopic diseases (Nylund et al., 2012). At age of one already most 
of the intestinal microbes are acquired and until the introduction of the molecular 
techniques it was believed that at that age microbiota is already adult-like (Mitsuoka, 
1992). Currently it is widely accepted that microbiota at age of three is adult like 
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(Yatsunenko et al., 2012), although quantitative differences have been observed even 
when comparing adults and children of 7-12 years of age (Hollister et al., 2015), or 
even adolescents (Agans et al., 2011). Despite the observed differences at later age, 
it is clear that the widest window of opportunity to shape microbiota and influence 
health is at very early age.  
In addition to mode of the delivery and infant feeding other factors such as 
presence of siblings or pets, antibiotic treatment and hospitalization also influence 
microbiota development (Laursen et al., 2015; Tun et al., 2017). Among these 
antibiotics have the most profound impact, although this depends on the antibiotic 
type (Ianiro, Tilg, & Gasbarrini, 2016). An interesting study conducted in Finland 
showed that macrolide antibiotic in contrast penicillin, both were prescribed for 
respiratory infections, induces dramatic changes in microbiota that are associated 
with increased obesity and allergy development risk (Korpela et al., 2016). Another 
important cofounder in microbiota shaping is diet. Dramatic differences in 
microbiota composition have been shown when European children were compared 
with rural African children (De Filippo et al., 2010). The analyses have shown that 
African children have an enriched population of bacteria that are capable of complex 
carbohydrate degradation, and although it has been suggested that diet is the major 
driver of the observed differences in the microbiota composition, it is clear that there 
are numerous genetic, cultural, hygienic and other lifestyle differences between the 
two compared populations that could have had their contribution to the observed 
dissimilarity. Since, other similar comparisons have shown a notable loss of 
microbial diversity and a composition shift in the developed societies, it has been 
suggested that microbiota change is underlining the increasing incidence of chronic 
diseases in the developed world. The data supporting this hypothesis was generated 
in a recent study that showed specific microbiota patterns and metabolites associated 
with increased risk for colon cancer development in African American population 
when compared to Native Africans (Ou et al., 2013). A dietary swop between these 
two populations induced shifts in microbiota composition and function, but also in 
the colonic biopsy histology indicating that diet is indeed the major driver in 
microbiota mediated health risks (O'Keefe et al., 2015). Even among elderly 
population, healthy and diverse diet was shown to be an important factor for reducing 
frailty and markers of inflammation while keeping microbiota diverse (Claesson et 
al., 2011). 
As expected, genetics is also an important factor that influences microbiota 
composition. Monozygotic twins have more alike microbiota than dizygotic twins 
and the level of similarity decreases with decreasing relatedness (Tims et al., 2013; 
Zoetendal, Akkermans, Akkermans-van Vliet, de Visser, & de Vos, 2001). Here, 
again, it is impossible to exclude other factors, such as shared environment, and 
similar dietary habits that are confounding factors in shaping microbiota. The 
undoubtable influence of the genetics on the microbiota is confirmed through 
established connection between specific genetic variants and microbiota composition 
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as shown for several genes (Blekhman et al., 2015; Olivares et al., 2015; Wacklin et 
al., 2014). The influence of host exceeds that of genetic background since specific 
micro RNAs produced by gut epithelium cells are able to enter bacterial cells and 
regulate their function (Liu et al., 2016). Experiments with laboratory animals 
showed that inability to produce these micro RNAs was linked with microbiota 
compositional shift and more severe parameters of the induced colitis. This 
sophisticated regulation is complemented with the immune regulation both by innate 
and adaptive elements of the immune system and indicates the complexity of the 
bidirectional host-microbe interactions. 
 
Link between Microbiota and Behavior 
 
There is an increasing evidence showing the importance of microbiota for 
systemic health, and one of the most intriguing aspects of microbiota influence is its 
contribution to the so-called gut brain axis. There are several health conditions that 
linked with behavioral changes and specific microbiota signatures. These include 
irritable bowel syndrome (IBS) (Jeffery et al., 2012; Rajilić-Stojanović et al., 2011), 
obesity (Ley et al., 2006) and even autism (Strati et al., 2017; Williams et al., 2012). 
The role of microbiota in obesity is complex and bidirectional. On one hand the 
disturbed microbiota could be a consequence of specific dietary habits of obese 
individuals, while on the other hand it could contribute to excessive energy extraction 
from diet (Turnbaugh et al., 2006). In addition, it has been shown that microbial 
metabolites, such as propionate, can act as satiety sensation molecules and therefore 
contribute to the eating behavior (Chambers et al., 2014), while propionate together 
with other short chain fatty acids produced during fermentation of dietary fiber 
promote metabolic benefits via gut-brain neural circuits (De Vadder et al., 2014). 
This basically means that introduction of non-digestible carbohydrates in the diet can 
promote activity of carbohydrate fermenting bacteria in the colon. As a consequence, 
beneficial metabolites that take part in blood glucose level regulation and satiety 
sensation will be produced, and this will contribute to healthy eating behavior.  
It is well established that in addition to gastrointestinal symptoms a large 
proportion (70-90%) of IBS patients have psychiatric comorbidity such as anxiety or 
depression (Garakani et al., 2003). Even though IBS is considered to be a functional 
disorder, recent years of research have shown that objective, measurable traits of this 
condition exist and include specific microbiota composition in at least some of the 
patients (Jeffery et al., 2012; Rajilić-Stojanović et al., 2011). Microbiota contribution 
to both gastrointestinal and psychiatric symptoms of IBS patients could be mediated 
through its impact on serotonin synthesis. The initial interest for studying this link 
came from the observation that germ free animals have about 6 fold lower level of 
serum serotonin level than conventional animals (Wikoff et al., 2009). Further 
research confirmed that serotonin is produced by hosts' enterochromaffin cells upon 
stimulation of these cells by microbial metabolites (Yano et al., 2015). While specific 
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microbes needed for this stimulation have not been identified yet, it seems that one 
of the major carbohydrate fermentation metabolites – butyrate is essential for 
serotonin synthesis induction (Reigstad et al., 2015). 
Autism represents one of the most intriguing conditions linked with microbiota 
dysbiosis. Specific traits in microbiota signatures, although rarely reproduced, have 
been repeatedly reported (De Angelis et al., 2013; Strati et al., 2017; Williams et al., 
2012). However, the most convincing study indicating the importance of microbiota 
in autism comes from an open-label study that reported successful fecal microbiota 
transplantation in autistic children (Kang et al., 2017). Change of the microbiota 
community caused improvement of gastrointestinal but also behavioral symptoms in 
the treated children. 
In addition to fecal microbiota transplantation, which causes dramatic changes 
of the intestinal ecosystem, literature data indicates that less aggressive microbiota-
targeting therapies can have a significant effect on behavior. The effect of early age 
probiotic treatment of Finish infants was evaluated 13 years later, and showed that 
placebo in contrast to probiotic treated children had significantly higher incidence of 
diagnosed attention deficit hyperactivity disorder and Asperger syndrome (Pärtty, 
Kalliomäki, Wacklin, Salminen, & Isolauri, 2015). The observed neuropsychiatric 
disorders were linked with lower abundance of Bifidobacterium spp. in 13 year old 
children. Another study showed that treatment with a probiotic can influence serum 
kyneurenic acid to kynurenine ratio (neuroprotective ratio) in line with attenuation 
of pro-inflammatory immune responses in experimental animals (Desbonnet, 
Garrett, Clarke, Bienenstock, & Dinan, 2008). Finally, it is of importance to note that 
recently the probiotic strains with antidepressant properties have been successfully 





Microbiota is an extremely numerous and complex ecosystem that has a 
profound and systemic impact on human health. Its complexity, variation, functional 
redundance and bidirectional communication with the host hamper establishment of 
clear cause-relation links with a number of diseases in which microbiota dysbiosis 
has been detected. A number of genetic and environmental factors shape microbiota 
and the most relevant imprint in this ecosystem and subsequent health is made in 
very early childhood. Manipulation of microbiota at older age can be performed by 
dietary shifts, probiotic treatments or fecal microbiota transplantation. These 
therapies can lied to the improvement in various health aspects, proving that 
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Los humanos viven en la relación cercana con el ecosistema microbiano complejo que se denomina 
microbioma. La microbioma está concentrada en la última parte del tracto gastrointestinal, donde 
fermenta los residuos de la comida no digerida y produce varios metabolitos que tienen influencia 
sistemática en la fisiología humana. La composición de la microbioma está influenciada por los 
factores genéticos y ambientales que forman un ecosistema único en cada humano. A pesar de las 
variaciones composicionales considerables, el output funcional del ecosistema es muy similar en 
todos los individuales sanos. Aunque todavía no es posible definir la microbioma normal, las 
comparaciones entre los pacientes que sufren algunas enfermedades crónicas con etiología 
desconocida y los controles han demostrado que los pacientes tienen una composición específica, 
disbiótica de microbioma. Mientras todavía queda por determinar si la disbiosis de la microbioma 
es un factor etiológico o consecuencia de la enfermedad, estos hallazgos han estimulado 
investigaciones intensivas de la microbioma. Numerosas funciones atestadas de microbioma 
incluyen la contribución a la digestión, síntesis de metabolitos esenciales (vitaminas y aminoácidos) 
y diafonía intensiva con los sistemas inmune, endocrino y nervioso. Aunque este campo de 
investigación todavía está en una fase temprana, está claro que los metabolitos microbianos tienen 
varios efectos en los humanos, incluyendo efecto beneficial directo, toxicidad, pero también 
interacciones más finas, dado que los productos microbianos pueden funcionar como moléculas de 
regulación inmune y de neuro-señalización. La red compleja de interacciones bidireccionales entre 
la microbioma y los humanos está por explorar con potencial muy alto para desarrollar estrategias 
novedosas para preservar y mejorar la salud. 
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